Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1094424
Reference Type
Journal Article
Title
STUDIES ON PROLINE BORONIC ACID DIPEPTIDE INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV - IDENTIFICATION OF A CYCLIC SPECIES CONTAINING A B-N BOND
Author(s)
Snow, RJ; Bachovchin, WW; Barton, RW; Campbell, SJ; Coutts, SJ; Freeman, DM; Gutheil, WG; Kelly, TA; Kennedy, CA; Krolikowski, DA; Leonard, SF; Pargellis, CA; Tong, L; Adams, J
Year
1994
Is Peer Reviewed?
Yes
Journal
Journal of the American Chemical Society
ISSN:
0002-7863
EISSN:
1520-5126
Volume
116
Issue
24
Language
English
Abstract
The proline boronic acid dipeptides AlaboroPro (14), ProboroPro (15), and ValboroPro (16) are very potent inhibitors of the enzyme dipeptidyl peptidase IV (DPP IV or CD26), found on the surface of T-cells, and are a new class of immunosuressants. The efficient synthesis of the free boronic acids as single enantiomers is described, and the absolute configuration determined. These compounds are known to lose DPP IV inhibitory activity in solution: this is shown to be due to the reversible formation of a cyclic species analogous to a diketopiperazine, containing a B-N bond. The cyclic compounds, both as the free boronic acids (17-19) and as the pinanediol esters (11-13), have been isolated and characterized by H-1 and B-11 NMR, and in one case by X-ray crystallography. The cyclization is pH dependent, with the open form favored at low pH, while the cyclic form predominates at neutral pH. Both the rate and extent of cyclization depend on the N-terminal amino acid. The rates of cyclization have been measured by H-1 NMR and shown to correlate with the decrease in DPP IV inhibitory activity. ValboroPro cyclizes more slowly, and to a lesser extent than AlaboroPro or ProboroPro, which is predicted to lead to greater immunosuppressive potency in vivo.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity